2.10

2.78% -0.06

After Hours: 2.02 -0.08 -3.81%

Processa Pharmaceuticals Inc (PCSA)

Overview News Price History Financials Discussions Forecast Stock Split

Processa Pharmaceuticals Inc stock is traded at $2.10, with a volume of 57,246. It is down -2.78% in the last 24 hours and down -16.67% over the past month. Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products. The company's strategic prioritization is to advance its pipeline of NGC proprietary small-molecule oncology drugs. The NGC products are new chemical entities, but the company works by changing the metabolism, distribution, and/or elimination of already FDA-approved cancer drugs or their active metabolites while maintaining the mechanism of how the drug kills cancer cells. The four NGC treatments in its pipeline are PCS6422 (also referred to as NGC-Cap), PCS11T, also referred to as NGC-Iri, is an analog of SN38, and PCS11T, PCS12852, and PCS499.

Previous Close:

$2.16

Open:

$2.13

24h Volume:

57,246

Relative Volume:

0.87

Market Cap:

$5.81M

Revenue:

Net Income/Loss:

$-14.11M

P/E Ratio:

-0.1959

EPS:

-10.7181

Net Cash Flow:

$-13.60M

1W Performance:

+8.25%

1M Performance:

-16.67%

6M Performance:

-37.87%

1Y Performance:

-56.88%

1-Day Range:

$2.0158

$2.18

1-Week Range:

$1.87

$2.3799

52-Week Range:

$1.76

$14.24

Processa Pharmaceuticals Inc Stock (PCSA) Company Profile

Name

Processa Pharmaceuticals Inc

Sector

Healthcare (1100)

Industry

Biotechnology (615)

Phone

443-776-3133

Address

601 21ST STREET, SUITE 300, VERO BEACH

Employee

Twitter

Next Earnings Date

2026-08-06

Latest SEC Filings

PCSA's Discussions on Twitter

Compare PCSA vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PCSA Processa Pharmaceuticals Inc	2.10	5.31M	0	-14.11M	-13.60M	-10.72
VRTX Vertex Pharmaceuticals Inc	529.59	126.07B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	649.81	65.37B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	916.80	57.70B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	313.04	40.19B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	189.99	39.82B	742.00K	-1.37B	-1.07B	-7.0731

Processa Pharmaceuticals Inc Stock (PCSA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-25-24	Initiated	H.C. Wainwright	Buy

Processa Pharmaceuticals Inc Stock (PCSA) Latest News

Jul 01, 2026

Insider Buying: Russell Skibsted Acquires Additional Shares of P - GuruFocus

Jul 01, 2026

Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock - Investing.com

Jul 01, 2026

Processa Pharmaceuticals CEO George Ng acquires $5,900 in stock By Investing.com - Investing.com Nigeria

Jul 01, 2026

Form 4 Processa Pharmaceuticals Inc For: 1 July By Investing.com - Investing.com Canada

Jul 01, 2026

Insider purchase: Processa (NASDAQ: PCSA) CAO adds 2,436 shares in open-market buy - Stock Titan

Jul 01, 2026

Processa (PCSA) strategy chief adds 2,106 shares in insider buy - Stock Titan

Jul 01, 2026

Processa Pharmaceuticals (PCSA) CEO adds 3,057 shares in open-market buy - Stock Titan

Jul 01, 2026

CFO of Processa (NASDAQ: PCSA) adds 3,277 shares in open-market buy - Stock Titan

Jul 01, 2026

Processa Pharmaceuticals (PCSA) director buys 2,531 shares in open market - Stock Titan

Jul 01, 2026

Processa Pharmaceuticals, Inc. Financial Disclosures & SEC Filings - TradingView

Jul 01, 2026

Jun 30, 2026

Form 4 Processa Pharmaceuticals Inc For: 30 June By Investing.com - Investing.com Canada

Jun 30, 2026

Processa (NASDAQ: PCSA) director Yorke vests 203-share restricted stock award - Stock Titan

Jun 30, 2026

[Form 4] Processa Pharmaceuticals, Inc. Insider Trading Activity - Stock Titan

Jun 30, 2026

Processa Pharmaceuticals (PCSA) director receives 203 shares from vesting - Stock Titan

Jun 30, 2026

Processa Pharmaceuticals (PCSA) director gets 203 shares from service award - Stock Titan

Jun 30, 2026

Jun 26, 2026

Price to sales forward of Processa Pharmaceuticals, Inc. – NASDAQ:PCSA - TradingView

Jun 26, 2026

Price to earnings forward of Processa Pharmaceuticals, Inc. – NASDAQ:PCSA - TradingView

Jun 26, 2026

Jun 25, 2026

Processa Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:PCSA) - TradingView

Jun 25, 2026

Jun 21, 2026

PCSA | Processa Pharmaceuticals, Inc. Common Executive Compensation - Quiver Quantitative

Jun 21, 2026

Jun 18, 2026

Shareholders to vote on Processa (NASDAQ: PCSA) equity plan and pay - Stock Titan

Jun 18, 2026